ACI is currently enrolling patients in a longitudinal sample collection study to investigate disease progression in healthy and early-stage CKD patients. This year long study is looking for dogs with Stage 1 or early Stage 2 CKD, as well as healthy dogs for participation.| ACI Biosciences
ACI is currently enrolling patients in a multicenter, randomized, masked, placebo-controlled, clinical trial to evaluate the safety and effectiveness of a potential new treatment for canine chronic inflammatory enteropathy (also known as idiopathic inflammatory bowel disease or IBD). The post Dogs with Chronic Inflammatory Enteropathy appeared first on ACI Biosciences.| ACI Biosciences
ACI is currently enrolling patients in a prospective, randomized, placebo-controlled, multicenter clinical trial to evaluate the safety and effectiveness of an investigational oral therapy for the control of seizures in treatment naïve dogs with idiopathic epilepsy.| ACI Biosciences
ACI is currently enrolling patients in a multicenter, randomized, placebo-controlled, clinical trial to evaluate the safety and effectiveness of a potential new injectable treatment for postoperative pain control in dogs undergoing TPLO surgery.| ACI Biosciences
This fully funded, randomized, placebo-controlled clinical trial will assess a potential new treatment for oral melanoma in dogs.| ACI Biosciences
